✦ LIBER ✦

P-620 Gefitinib (‘Iressa’, ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small-cell lung cancer (NSCLC)

✍ Scribed by Park, Jinny; Park, Byeong-Bae; Lee, Se-Hoon; Park, Se Hoon; Lee, Kyung-Eun; Lee, Soon; Nam, Eunmi; Park, Joon Oh; Lim, Young-Hyuck; Park, Keunchil

Book ID: 118572315
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 174 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92587-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of ZD1839 (Gefitinib, Iressa™)

Activity of ZD1839 (Gefitinib, Iressa™) in Previously Treated Patients with Recurrent and Advanced non—small-Cell Lung Cancer

✍ Angelia D. Gibson; Mark Socinski; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 79 KB

P-617 Gefitinib (ZD 1839, Iressa) as a l

P-617 Gefitinib (ZD 1839, Iressa) as a last option for patients with recurrent non-small cell lung cancer (NSCLC)

✍ Haringhuizen, Annebeth; Vaessen, Heleen F.R.; Baas, Paul; van Zandwijk, Nico 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

P-587 Experience from a large multi-cent

P-587 Experience from a large multi-centre expanded access programme (EAP) with gefitinib (‘Iressa’, ZD1839) as monotherapy in advanced non-small cell lung cancer (NSCLC)

✍ van Puijenbroek, R.; Bosquée, L.; Tits, G.; Germonpre, P.; Strobbe, E.; Vansteen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 294 KB

P-612 Gefitinib (Iressa, ZD1839) is acti

P-612 Gefitinib (Iressa, ZD1839) is active as first-line, compassionate use therapy in patients with advanced non-small cell lung cancer (NSCLC)

✍ Argiris, Athanassios; Mittal, Namrata; Masters, Gregory 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB

P-613 The Israeli experience with gefiti

P-613 The Israeli experience with gefitinib (‘Iressa’, ZD1839) as single agent treatment of advanced non-small-cell lung cancer

✍ Gips, M.; Heching, Y.; Levitt, M.; Kuten, A.; Shmueli, E.; Segal, A.; Peretz, T. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB

PCNI9 NEW TARGETED THERAPY FOR PATIENTS

PCNI9 NEW TARGETED THERAPY FOR PATIENTS WITH PREVIOUSLY-TREATED ADVANCED NON-SMALL CELL LUNG CANCER—GEFITINIB (“IRESSA”)

✍ R de Peuter; A Antonisse; J van Loon; J Brown 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB